by Lluis Llorens | Jun 2, 2024 | Synthesis of Drugs
FollowFollowFollow Oliceridine Oliceridine is an opioid medication that was approved by the FDA for the treatment of moderate to severe acute pain in adults. The medication is indicated for short-term intravenous use in hospitals and other controlled clinical...
by Lluis Llorens | Mar 9, 2024 | Named Reactions, Nezaradené
The Chemists’ Cookbook Waitlist Are you interested in the Chemists' Cookbook? Join the exclusive waitlist and be the first to know when my new book is released. As a waitlist member, you will get a special pre-launch discount on the book. You're in! Name...
by Lluis Llorens | Mar 2, 2024 | Transformations
FollowFollowFollow Protection of Amines This post is about reactions involving the protection of amines in organic chemistry. The post is active and growing, so you can expect more examples to be added over time. Please be sure to come back. The updates will be...
by Lluis Llorens | Nov 12, 2023 | Transformations
FollowFollowFollow Protection of Alcohols This post is about reactions involving the protection of alcohols in organic chemistry. The post is active and growing, so you can expect more examples to be added over time. Please be sure to come back. The updates will be...
by Lluis Llorens | Nov 3, 2023 | Synthesis of Drugs
FollowFollowFollow Futibatinib Futibatinib is a medication that in September 2022 received accelerated approval by the FDA for the treatment of cholangiocarcinoma. Disease: oncology Target: FGFR – Tyrosine Kinase. Mechanism of Action: Irreversible inhibitor. ...
